A Novel Valsalva Assist Device for Terminating Supraventricular Tachycardia

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 212 participants.

Also called NCT06622772

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 212 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06622772
Other papers using this trial's data
  • Device-Assisted vs Standard Valsalva Maneuver for Terminating Supraventricular Tachycardia: A Randomized Clinical Trial JAMA cardiology, 2026-03-01 DOI, PubMed 41670992, PMC12895315 PubMed links an erratum for this paper. Erratum: PMID 42054045 Not in the PMC Open Access subset.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06622772. Randomized; no masking; primary purpose treatment. Start 2022-03-01 (actual); primary completion 2023-04-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Novel Valsalva Assist Device for Terminating Supraventricular Tachycardia
Condition
Supraventricular Tachycardia (SVT)
Intervention (Device)
Valsalva assist device
Intervention (Other)
standard Valsalva manoeuvre
Lead sponsor
Beijing Anzhen Hospital (class: other)

Record details

Record id
cardio:ct-nct06622772
Content hash
83969dc14dc43b475574d723294bf953667f64a0c55be01f2284467090af61ed